-
International Journal of Nanomedicine
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Dr Webster
Editor-in-Chief: Dr. Thomas J. Webster
Thomas J. Webster is an Associate Professor for the Division of Engineering at Brown University and the Division of Orthopedic Surgery at Brown University Medical School. He has degrees in chemical engineering from the University of Pittsburgh (BS, 1995) and in biomedical engineering from Rensselaer Polytechnic Institute (MS, 1997; PhD, 2000). Prof Webster’s research addresses the design, synthesis, and evaluation of nanophase materials (that is, materials with fundamental length scales less than 100 nm) as more effective biomedical implants. Prof Webster is the current director of the Nanostructured Biomaterials Laboratory and has completed extensive studies on the use of nanophase materials as implanted materials. His lab group has produced 4 books, 15 book chapters, 62 invited presentations, 157 literature articles and conference proceedings, 245 conference presentations, and 15 provisional or full patents on the study of nanophase materials and implantable devices. Prof Webster’s research on nanophase materials has received attention in numerous recent media publications such as MSNBC News, June 1, 2004; the Economist, June 5, 2004; and Chemical and Engineering News, Feb 28, pp. 39–42, 2000. He has organized more than 25 symposia at academic conferences highlighting the use of nanomaterials in biological applications. Other honors include: 2000, Karen and Lester Gerhardt Graduate Student Award in recognition of outstanding academic achievement and promise for a successful career, Rensselaer Polytechnic Institute; 2002, Biomedical Engineering Society Rita Schaffer Young Investigator Award; 2004, Purdue University Young Investigator Award from the Schools of Engineering; 2005, Finalist for the Young Investigator Award for the American Society for Nanomedicine; and 2004, Early Career Award from the Coulter Foundation. He currently serves as the Editor-in-Chief of the International Journal of Nanomedicine and is on the Editorial Board of Biomaterials, American Society for Artificial Internal Organs, International Journal of Nanomanufacturing, and Journal of Biomedical Nanotechnology.
Dr Hilt
US Associate Editor: J. Zach Hilt
J. Zach Hilt is an Assistant Professor of Chemical Engineering in the Department of Chemical and Materials Engineering at the University of Kentucky. Prof. Hilt received his bachelor degrees in Chemistry and Physics from Miami University (Ohio). He completed his Masters degree in Chemical Engineering from Purdue University and his Doctor of Philosophy in Chemical Engineering from the University of Texas at Austin. Prof. Hilt’s research laboratory focuses on the design of novel hydrogel biomaterials, the development of novel methods to synthesize and characterize the hydrogels at the micro- or nanoscale, and the application of these materials as biomedical devices or functional components of biomedical devices. Prof. Hilt has authored numerous referred publications, including a recent review “Hydrogels in Biology and Medicine: From Molecular Principles to Bionanotechnology” published in Advanced Materials. He is co-editor of “Nanotechnology in Therapeutics: Current Technology and Applications” which is published by Horizon Scientific Press and is one of the first books dedicated to the topic of nanotechnology in drug delivery. Prof. Hilt was an invited participant in the 2008 German-American Frontiers of Engineering Symposium (GAFOE), which was co-organized by the National Academy of Engineering (NAE) and the Alexander von Humboldt Foundation. He is a member of the Materials Research Society, American Institute for Chemical Engineers, Society for Biomaterials, American Chemical Society, and the Controlled Release Society. He has taken an active role in these professional societies, including co-organizing the Bionanotechnology Topical Conference at the Annual AIChE Meeting for the past few years.
Dr Katti
South Asia Associate Editor: Dr. Dhirendra S. Katti
Dr. Dhirendra S. Katti is an Associate Professor at the department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur, India. Dr. Katti received his B.Sc. in Chemistry from Fergusson College, Poona University, India (1990), B.Sc. Tech. in Chemical Technology from University Institute of Chemical Technology (U.I.C.T.), University of Mumbai, India (1993), and Ph.D. in Chemistry from University of Mumbai, India (1999). Dr. Katti then did his post-doctoral fellowship at Department of Chemical Engineering, Drexel University, Philadelphia, USA on Drug Delivery Systems and Tissue Engineering (1999-2001) and later accepted the position of Research Assistant Professor at Drexel Unviersity where he initiated projects in the area of Nanotechnology and Tissue Engineering (2001-2003). Dr. Katti then moved on as Assistant Professor at the Department of Orthopaedic Surgery and the Department of Biomedical Engineering at The University of Virginia (2003-2004) before returning to India in 2004.
Dr. Katti is an editorial board member of the “Journal of Biomedical Nanotechnology”, published by American Scientific Publishers and “Recent Patents on Biomedical Engineering” published by Bentham Science Publishers. In addition, Dr. Katti has been Section Editor for a book entitled “Bone Graft Substitutes” Published by ASTM, USA (2003) and has been Guest Editor for Engineering in Medicine and Biology Magazine’s Special Issue on Tissue Engineering (2003). Recently, Dr. Katti has co-edited a book on “Advanced Biomaterials” to be published by John Wiley & Sons (2009). His current research interests are in the areas of Biomaterials, Drug Delivery Systems, Tissue Engineering and Nano-Biotechnology.
Dr Khang
East Asia Associate Editor: Dongwoo Khang
Dr. Khang is a lab director of medicinal nanostructured biomaterials and a faculty member in Gyeongsang National University. His lab is jointly supported by both Center for Nano-Morphic Biological Energy (funded by NRF) and School of Nano and Advanced Materials Engineering in Gyeongsang National University. He is also leading research projects as PI (funded by NRF) at the intersection of nanostructured biomaterials, immunology, oncology, toxicology and medicine/pharmacology.
His current research interest is to understand fundamental mechanism of cellular and immune-toxicity signal pathways by altering nanoscaled materials/mechanical properties. His research articles were highlighted in the journal of Biomaterials as one of the hottest papers (2008), cited in review article in Nature Nanotechnology (2009) and also highlighted in ACS Bulletin (American Ceramic Society)/American Scientific (2009). He is a winner of outstanding presentation award with his advised students, endowed by the Materials Research Society of Korea (MRS-K) in 2009 (both spring and fall) and in 2010 (spring). He also served as a session chair in US/Korea conferences.
He completed his PhD in Purdue University at the Physics/Biomedical Engineering on 2006. Then, he was a post doctor research associate in Brown University at the Biomedical Division during 2006-2008. He worked in a pharmaceutical research company in Boston as a senior staff scientist before joining as a faculty member in Gyeonsang National University in 2009. He received MS and BS degrees from Seoul National University and Kyunghee University.
Professor Khademhosseini
US Associate Editor: Ali Khademhosseini
Ali Khademhosseini is an Assistant Professor of Medicine and Health Sciences and Technology at Harvard-MIT's Division of Health Sciences and Technology and the Harvard Medical School. His research is based on developing micro- and nanoscale technologies to control cellular behavior with particular emphasis in developing microscale biomaterials and engineering systems for tissue engineering. His laboratory is currently pioneering technologies to control the formation of vascularized tissues with appropriate microarchitectures as well as regulating stem cell differentiation within microengineered systems. He has published 2 edited books, 80 peer reviewed papers, 20 book chapters, 100+ abstracts, and 17 patent applications. His work has been published in journals such as PNAS, JACS, Advanced Materials, Biomaterials and Lab on a chip and highlighted in Nature, Scientific American and Technology Review Magazine. He has chaired and organized numerous symposia and sessions in the area of BioMEMS, micro and nanofabricated biomaterials, and micro/nanoscale drug delivery/tissue engineering. Also, he has been invited to give greater than 80 seminars at various academic and industrial institutions. Dr. Khademhosseini’s research efforts have earned him the NSF CAREER award (2009), the Technology Review Magazine "Top Young Innovator” (TR35) award (2007), the BMW Group Scientific award (2007), the ACS Victor K. LaMer award (2008), the Coulter Foundation Early Career award (2006), International Academy of Medical and Biological Engineering (IAMBE) Young Faculty award (2009) and the IEEE-EMBS (IEEE- Engineering in Medicine and Biology) Early Career award (2008). Khademhosseini's teaching efforts were recognized as MIT’s Outstanding Undergraduate mentor (2004). He received his Ph.D. in bioengineering from MIT (2005), and MASc (2001) and BASc (1999) degrees from University of Toronto both in chemical engineering.
Professor Rubinstein
US Associate Editor: Professor Israel (Rudi) Rubinstein
Dr. Rubinstein is Professor of Medicine and Biopharmaceutical Sciences in Colleges of Medicine and Pharmacy, University of Illinois at Chicago, Chicago, Illinois, U.S.A. He is attending physician in pulmonary, critical care and sleep medicine at the University of Illinois at Chicago and Jesse Brown VA Medical Center, Chicago, Illinois, U.S.A. Dr. Rubinstein received his M.D. from Hebrew University-Hadassah School of Medicine in Jerusalem, Israel. He trained in internal medicine in Israel and in Respirology at the University of Toronto, Toronto, Ontario, Canada. He was post-doctoral research fellow at Cardiovascular Research Institute, University of California San Francisco, San Francisco, California, U.S.A. Thereafter, Dr. Rubinstein was awarded Research Career Developmental Award by the National Institutes of Health, Bethesda, Maryland, U.S.A. His research focuses on nanomedicine, drug delivery and bioimaging in inflammation and cancer. He is Associate Editor, Journal of Biomedical Nanotechnology and member of Editorial Boards of Angiology, Clinical and Molecular Allergy, Clinical Medicine: Arthritis and Musculoskeletal Disorders, Current Respiratory Medicine Reviews, Hypertension, Journal of Heart Disease, Nanotechnology, Science and Applications, Recent Patents on CNS Drug Discovery, Respiration and The Open Sports Medicine Journal. Dr. Rubinstein serves on Board of Directors of Advanced Life Sciences, a publicly-traded pharmaceutical company, Woodridge, Illinois, U.S.A. He has 5 U.S.A.-issued patents and several pending and provisional patents.
Professor Souto
European Associate Editor: Professor Eliana B. Souto
Eliana B. Souto is Professor of Pharmaceutical Technology in the Faculty of Health Sciences at University Fernando Pessoa in Porto, Portugal. Professor Souto is graduated in Pharmaceutical Sciences from the Faculty of Pharmacy, University of Coimbra. She also obtained a post-graduated Master degree in Pharmaceutical Technology and Pharmacotechnique at the Faculty of Pharmacy, University of Porto, and awarded with the degree of PhD in Pharmaceutical Technology, Biopharmaceutics and Biotechnology at the Institute of Pharmacy, Free University of Berlin, Germany. In December 2007 she has been awarded with the Women In Science 2007 L’Oreal Portugal Prize, supported by UNESCO and the Portuguese Science and Technology Foundation, and granted by L’Oreal Portugal. Nowadays, Professor Souto coordinates the Euro-PhD in Advanced Drug Delivery from Galenos Network in her Faculty. Her research group is devoted to the design, development, and characterization of new drug delivery systems based on colloidal carriers. Other research interests are the controlled delivery of drugs across biological barriers, namely skin, gastrointestinal tract and blood-brain-barrier. Professor Souto is on the Editorial Board of the Journal of Biomedical Nanotechnology, Die Pharmazie and Current Nanoscience, and is a member of the Advisory Board of several other peer-reviewed scientific journals.
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- Interested in being a peer-reviewer?
Click here to register.
- Display new articles on your site
Use our widget to show articles on your own site




